Des-N-(1-3) IGF-1, commonly known as IGF-1 DES, is a modified peptide derived from insulin-like growth factor 1. By lacking the first three amino acids, IGF-1 DES exhibits improved efficacy in vitro. Its reduced binding to insulin-like growth factor binding proteins (IGFBPs) allows for greater availability and enhanced anabolic effects. As per research results it indicates potential applications in promoting neuronal recovery and muscle development highlighting IGF-1 DES's role in therapies aimed at neurological injuries and muscle repair.
Frontiers in CNS Drug Discovery (2011) Frontiers in CNS Drug Discovery. Bentham Science Publishers.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about IGF-1 DES by Deus Medical, consult with your doctor or healthcare professional.
Frontiers in CNS Drug Discovery (2011) Frontiers in CNS Drug Discovery. Bentham Science Publishers.
Frontiers in CNS Drug Discovery (2011) Frontiers in CNS Drug Discovery. Bentham Science Publishers.
Frontiers in CNS Drug Discovery (2011) Frontiers in CNS Drug Discovery. Bentham Science Publishers.
Home
